Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew C Johns"'
Autor:
Andrew C, Johns, Matthew T, Campbell
Publikováno v:
The Cancer Journal. 28:469-478
Antibody-drug conjugates are becoming increasingly important in the treatment of many cancer types. The 3 main structural components-antibody, linker, and payload-each contribute to the toxicity profiles of these drugs. In addition to cytopenias and
Autor:
Suk ho Hong, Sarah Y. Xi, Andrew C. Johns, Lauren C. Tang, Allyson Li, Madeleine N. Hum, Cassandra A. Chartier, Marko Jovanovic, Neel H. Shah
Publikováno v:
Chembiochem
Protein tyrosine phosphatases (PTPs) are an important class of enzymes that modulate essential cellular processes through protein dephosphorylation and are dysregulated in various disease states. There is demand for new compounds that target the acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::301fb4585689c8eb55a3d762a8afbc23
https://europepmc.org/articles/PMC10192133/
https://europepmc.org/articles/PMC10192133/
Autor:
Andrew C Johns, Mike Yang, Lai Wei, Madison Grogan, Daniel Spakowicz, Sandipkumar H Patel, Mingjia Li, Marium Husain, Kari L Kendra, Gregory A Otterson, Ashley E Rosko, Barbara L Andersen, David P Carbone, Dwight H Owen, Carolyn J Presley
Publikováno v:
The Oncologist.
Objectives Immune checkpoint inhibitor immunotherapy (IO) is revolutionizing cancer care but can lead to significant toxicity. This study seeks to describe potential risk factors for immune-related adverse events (irAEs) specifically among older adul
Autor:
Andrew C. Johns, Mike Yang, Lai Wei, Madison Grogan, Sandipkumar H. Patel, Mingjia Li, Marium Husain, Kari L. Kendra, Gregory A. Otterson, Jarred T. Burkart, Daniel Spakowicz, Rebecca Hoyd, Dwight H. Owen, Carolyn J. Presley
Publikováno v:
Cancer Immunology, Immunotherapy.
Autor:
Suk ho Hong, Sarah Y Xi, Andrew C Johns, Lauren C Tang, Allyson Li, Marko Jovanovic, Neel H Shah
Protein tyrosine phosphatases (PTPs) are an important class of enzymes that modulate essential cellular processes through protein dephosphorylation and are dysregulated in various disease states. There is demand for new compounds that target the acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d5ed2a67db429e336d410d1e7395825
https://doi.org/10.26434/chemrxiv-2022-1rnqh
https://doi.org/10.26434/chemrxiv-2022-1rnqh